Physician profile
Gary N Ackerman
NPI 1710970322
$3,629.17
in general payments reported to CMS, 2019-2025
22 companies · $898 in 2025
The $898 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $294 · 2021: $108 · 2022: $526 · 2023: $211 · 2024: $1,238 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,347.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $911.62 | 2019-2025 | Insignia, T2 Alpha, Pangea |
| Zimmer Biomet Holdings, INC. | $835.98 | 2022-2025 | Mymobility Platform, Tapestry, Persona |
| Smith+Nephew, INC. | $583.71 | 2019-2025 | Real Intelligence, Evos, Legion Revision |
| Vericel Corporation | $281.48 | 2020-2025 | Maci |
| Sanara Medtech INC. | $216.81 | 2024-2025 | Celleraterx, Celleraterx |
| Heron Therapeutics, INC. | $179.97 | 2022-2025 | Zynrelef |
| Depuy Synthes Sales INC. | $102.31 | 2019-2022 | |
| Djo, LLC | $91.75 | 2019-2024 | Cmf |
| Vertex Pharmaceuticals Incorporated | $60.39 | 2025 | |
| Southern Edge Orthopaedics, INC. | $56.86 | 2024 | |
| Abbott Laboratories | $43.83 | 2024 | Eterna |
| C. R. Bard, INC. & Subsidiaries | $40.58 | 2024 | |
| Ermi LLC | $39.90 | 2019-2022 | |
| Convatec INC. | $29.95 | 2024-2025 | |
| Kci USA, INC. | $24.34 | 2023 | Prevena |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $23.10 | 2021 | |
| Molnlycke Health Care US, LLC | $23.05 | 2024 | Mepilex Border Post-Op Ag, Avance |
| Davol INC. | $19.83 | 2022 | |
| Bioventus LLC | $18.64 | 2023 | Durolane |
| Zyla Life Sciences, INC. | $17.97 | 2020 | |
| Horizon Therapeutics Plc | $16.30 | 2020 | |
| Sientra, INC. | $10.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Ackerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.